Mincle and STING Activation in Proinflammatory Responses to Orientia Infection

Mincle 和 STING 激活对 Orientia 感染的促炎反应

基本信息

  • 批准号:
    10372040
  • 负责人:
  • 金额:
    $ 19.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-15 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Scrub typhus is a life-threatening disease caused by Orientia tsutsugamushi, an LPS-negative bacterium. This bacterium is highly infectious, replicating preferentially in phagocytes and endothelial cells, leaving one third of world population at risk of infection. Scrub typhus vaccines are not yet available; information on host immune recognition and disease pathogenesis is limited. Our recently developed mouse models of O. tsutsugamushi Karp strain infection, which mimic severe infection in human patients, have revealed that excessive type 1, but deficient type 2, immune responses result in acute vascular damage in multiple organs. Using the NanoString technology, we examined more than 1,200 immune genes in inflamed tissues (lung, spleen, brain). We found a significant/selective increase in transcripts of Mincle/Clec4e (a C-type lectin receptor) and STING (a DNA sensor) during acute/lethal infection in mice and in infected primary phagocyte cultures. The underlying hypothesis is that Mincle/STING pathway activation in O. tsutsugamushi-infected monocytes are critical for effector T cell priming, and dysregulated Mincle/STING activation can lead to excessive type 1 inflammation and acute tissue damage. Aim 1 will test whether sustained bacterial replication can initiate Mincle and STING activation and trigger their downstream signaling pathways. Both mouse and human primary macrophages and monocytes will be used for in vitro infection under various conditions with normal or attenuated expression of Mincle or STING (via siRNA, pharmacological inhibitors, or genetic knockouts). Aim 2 will determine whether Mincle/STING activation in dendritic cells can effectively prime/activate T effector cells and if Mincle/STING contribute to dysregulated T-cell responses during Orientia infection. Dendritic cells from Mincle-/- and STING-/- C57BL/6J mice will be infected and examined for priming naïve CD4 T cells in vitro and in vivo; knockout mice will receive a non-lethal or lethal Orientia infection. The spectrum of innate and adaptive immune responses will be evaluated at the single-cell and molecular levels and integrated with those from bacteriologic/pathologic studies. While Mincle and STING ligands from certain human pathogens or damaged self-components are reported, the roles of Mincle or STING during Orientia infection have never been explored. This study will reveal, for the first time, how these innate sensors collectively contribute to host responses to an obligate intracellular bacterium, which is poorly studied but has public health impact. The feasibility is justified by our research expertise and BSL3 facilities. Discovery of the nature of initial immune activation/dysfunction will help reveal signature host profiles for scrub typhus prognosis and potential avenues for pharmacological intervention. This timely study will have broad implications for other intracellular pathogens.
项目总结/摘要 恙虫病是一种由恙虫病东方体(一种LPS阴性细菌)引起的危及生命的疾病。这 细菌是高度传染性的,优先在吞噬细胞和内皮细胞中复制,留下三分之一的 世界人口面临感染风险。丛林斑疹伤寒疫苗尚未问世;关于宿主免疫的信息 认识和发病机制有限。我们最近开发了O.恙虫 卡普菌株感染,模仿人类患者的严重感染,已经揭示了过量的1型,但 缺乏2型,免疫反应导致多个器官的急性血管损伤。使用NanoString 通过这项技术,我们检测了炎症组织(肺、脾、脑)中的1,200多个免疫基因。我们发现了一个 Mincle/Clec 4 e(一种C型凝集素受体)和STING(一种DNA 传感器)在小鼠急性/致死性感染期间和感染的原代吞噬细胞培养物中。底层 假设在O.恙虫病感染的单核细胞对于 效应T细胞引发和失调的Mincle/STING活化可导致过度的1型炎症 和急性组织损伤目标1将测试持续的细菌复制是否可以启动Mincle和STING 激活并触发其下游信号通路。小鼠和人的原代巨噬细胞和 单核细胞将用于在各种条件下的体外感染, Mincle或STING(通过siRNA、药理学抑制剂或基因敲除)。目标2将决定是否 树突状细胞中的Mincle/STING活化可以有效地引发/活化T效应细胞,并且如果Mincle/STING活化, 导致东方体感染期间T细胞反应失调。来自Mincle-/-和STING-/-的树突状细胞 将感染C57 BL/6 J小鼠,并检查体外和体内致敏幼稚CD 4 T细胞;敲除小鼠 将接受非致命或致命的东方体感染。先天性和适应性免疫反应谱 将在单细胞和分子水平上进行评价,并与细菌学/病理学水平相结合 问题研究虽然来自某些人类病原体或受损自身组分的Mincle和STING配体是 据报道,Mincle或STING在Orientia感染期间的作用从未被探索过。本研究将 揭示,第一次,这些先天传感器如何共同促进宿主对专性 细胞内细菌,这是研究不足,但有公共卫生的影响。可行性是由我们的 研究专业知识和BSL 3设施。发现初始免疫激活/功能障碍的本质将有助于 揭示了恙虫病预后的标志性宿主特征和药理学治疗的潜在途径 干预这项及时的研究将对其他细胞内病原体产生广泛的影响。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Distinct Role of TNFR1 and TNFR2 in Protective Immunity Against Orientia tsutsugamushi Infection in Mice.
  • DOI:
    10.3389/fimmu.2022.867924
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
Orientia tsutsugamushi selectively stimulates the C-type lectin receptor Mincle and type 1-skewed proinflammatory immune responses.
  • DOI:
    10.1371/journal.ppat.1009782
  • 发表时间:
    2021-07
  • 期刊:
  • 影响因子:
    6.7
  • 作者:
    Fisher J;Card G;Liang Y;Trent B;Rosenzweig H;Soong L
  • 通讯作者:
    Soong L
Orientia tsutsugamushi Infection Stimulates Syk-Dependent Responses and Innate Cytosolic Defenses in Macrophages.
  • DOI:
    10.3390/pathogens12010053
  • 发表时间:
    2022-12-29
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Fisher, James;Gonzales, Casey;Chroust, Zachary;Liang, Yuejin;Soong, Lynn
  • 通讯作者:
    Soong, Lynn
Host transcriptomic profiling of CD-1 outbred mice with severe clinical outcomes following infection with Orientia tsutsugamushi.
  • DOI:
    10.1371/journal.pntd.0010459
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Thiriot, Joseph;Liang, Yuejin;Fisher, James;Walker, David H.;Soong, Lynn
  • 通讯作者:
    Soong, Lynn
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LYNN SOONG其他文献

LYNN SOONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LYNN SOONG', 18)}}的其他基金

Pathogenic Mechanisms of Vascular Dysfunction in Scrub Typhus
恙虫病血管功能障碍的致病机制
  • 批准号:
    9753929
  • 财政年份:
    2018
  • 资助金额:
    $ 19.75万
  • 项目类别:
Pathogenic Mechanisms of Vascular Dysfunction in Scrub Typhus
恙虫病血管功能障碍的致病机制
  • 批准号:
    9982174
  • 财政年份:
    2018
  • 资助金额:
    $ 19.75万
  • 项目类别:
Pathogenic Mechanisms of Vascular Dysfunction in Scrub Typhus
恙虫病血管功能障碍的致病机制
  • 批准号:
    10204937
  • 财政年份:
    2018
  • 资助金额:
    $ 19.75万
  • 项目类别:
T-Cell Quality and Protective Immunity in a Murine Scrub Typhus Model
鼠恙虫病模型中的 T 细胞质量和保护性免疫
  • 批准号:
    9169476
  • 财政年份:
    2016
  • 资助金额:
    $ 19.75万
  • 项目类别:
Dysregulated type-1 and Vascular Responses in Scrub typhus Pathogenesis
恙虫病发病机制中 1 型失调和血管反应
  • 批准号:
    8873311
  • 财政年份:
    2015
  • 资助金额:
    $ 19.75万
  • 项目类别:
L. Brazilensis Vaccine Antigens and T-cell Quality in Protection
巴西乳杆菌疫苗抗原和保护中的 T 细胞质量
  • 批准号:
    8654289
  • 财政年份:
    2013
  • 资助金额:
    $ 19.75万
  • 项目类别:
Fifth World Congress of Leishmaniasis 2013
2013 年第五届世界利什曼病大会
  • 批准号:
    8529171
  • 财政年份:
    2013
  • 资助金额:
    $ 19.75万
  • 项目类别:
L. Brazilensis Vaccine Antigens and T-cell Quality in Protection
巴西乳杆菌疫苗抗原和保护中的 T 细胞质量
  • 批准号:
    8430973
  • 财政年份:
    2013
  • 资助金额:
    $ 19.75万
  • 项目类别:
Pathogenic Mechanisms of Cutaneous Leishmaniasis
皮肤利什曼病的发病机制
  • 批准号:
    7920778
  • 财政年份:
    2009
  • 资助金额:
    $ 19.75万
  • 项目类别:
Infectious Diseases and Inflammatory Disorders Training Program
传染病和炎症性疾病培训计划
  • 批准号:
    8742251
  • 财政年份:
    2008
  • 资助金额:
    $ 19.75万
  • 项目类别:

相似海外基金

Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Research Grant
The Association Between Aging, Inflammation, and Clinical Outcomes in Acute Respiratory Distress Syndrome
衰老、炎症与急性呼吸窘迫综合征临床结果之间的关联
  • 批准号:
    10722669
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
Sedatives Pharmacology in Acute Respiratory Distress Syndrome- SPA
急性呼吸窘迫综合征中的镇静药理学 - SPA
  • 批准号:
    491387
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Fellowship Programs
New mechanism-based TREM-1 therapy for acute respiratory distress syndrome
基于新机制的 TREM-1 疗法治疗急性呼吸窘迫综合征
  • 批准号:
    10678788
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
Great Lakes Clinical Center of the Acute Respiratory Distress Syndrome, Pneumonia and Sepsis (APS) Consortium
急性呼吸窘迫综合征、肺炎和败血症 (APS) 联盟五大湖临床中心
  • 批准号:
    10646578
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
Effect of ADAMTS13 on pathogenesis of acute respiratory distress syndrome
ADAMTS13 对急性呼吸窘迫综合征发病机制的影响
  • 批准号:
    23K08447
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
一种新型合成生物学衍生的微生物疗法,可治疗病毒引起的急性呼吸窘迫综合征(ARDS)
  • 批准号:
    10601865
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
Development of drug therapy targeting ferroptosis, iron-dependent cell death for acute respiratory distress syndrome.
开发针对铁死亡(急性呼吸窘迫综合征的铁依赖性细胞死亡)的药物疗法。
  • 批准号:
    23K08360
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Sustainable Implementation of Prone Positioning for the Acute Respiratory Distress Syndrome
持续实施俯卧位治疗急性呼吸窘迫综合征
  • 批准号:
    10722194
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
  • 批准号:
    10594793
  • 财政年份:
    2023
  • 资助金额:
    $ 19.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了